IDEXX Laboratories, Inc. IDXX
519.26
5.87
1.14%
as of 25 Sep
- Market cap
- $40.2B
- P/E
- 36.2×
Follow IDXX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 74.21% | 72.92% | 66.20% | 64.63% |
+8 more TTM periods Free account |
|
| 33.65% | 33.19% | 31.89% | 30.50% | ||
ROIC |
48.87% | 48.68% | 45.33% | 43.47% | |
Return on Tangible Assets |
119.33% | 122.43% | 104.65% | 106.50% | |
Average Days of Receivables |
50.27 | 49.55 | 46.85 | 49.65 | |
Free Cash Flow per Share |
15.67 | 13.28 | 11.89 | 10.78 | |
Free Cash Flow |
1,237.09 | 1,058.11 | 956.58 | 863.22 | |
Capital Expenditures |
(134.42) | (151.98) | (225.23) | (224.85) | |
Piotroski F-Score |
8.00 | 7.00 | 7.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
60.70% | 54.84% | 52.87% | 47.43% | |
Accounts Receivable Turnover |
7.67 | 7.86 | 8.39 | 7.73 | |
Accounts Payable Turnover |
13.92 | 13.49 | 14.64 | 13.70 | |
Inventory Turnover |
4.36 | 4.34 | 4.33 | 4.08 | |
Average Days of Payables |
27.56 | 28.12 | 24.51 | 27.97 | |
Days of Inventory on Hand |
83.59 | 82.73 | 83.86 | 89.59 | |
Tax Rate |
(0.20) | (0.20) | (0.20) | (0.19) | |
Research and Development Expense of Revenue |
5.74% | 5.80% | 5.84% | 5.81% | |
Selling, General and Administrative Expense of Revenue |
24.67% | 24.63% | 24.36% | 24.57% | |
Share Based Compensation of Revenue |
1.38% | 1.39% | 1.39% | 1.40% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.20 | 1.10 | 1.12 | 1.06 | |
Depreciation/Fixed assets |
0.21 | 0.20 | 0.19 | 0.19 | |
Capex/Depreciation |
(0.87) | (1.02) | (1.55) | (1.60) | |
Revenue per Share |
57.67 | 55.82 | 53.51 | 52.03 | |
Operating CF per Share |
17.37 | 15.19 | 14.69 | 13.58 | |
Capex per Share |
(1.70) | (1.91) | (2.80) | (2.81) | |
Capex to Sales |
0.03 | 0.03 | 0.05 | 0.05 | |
Net Profit Margin |
25.03% | 24.63% | 24.62% | 24.65% |
Columns are period end dates